Zobrazeno 1 - 10
of 75
pro vyhledávání: '"SH Embury"'
Publikováno v:
Blood. 78(1)
Hemoglobin (Hb) Constant Spring is an alpha-thalassemic hemoglobinopathy that is a major cause of severe alpha-thalassemia in Southeast Asians. The difficulty of diagnosing Hb Constant Spring using standard electrophoretic methods has led to interest
Autor:
Martin H. Steinberg, SH Embury
Publikováno v:
Blood. 68:985-990
Recent advances in molecular genetics have permitted detailed study of the human alpha-globin genes and the causes of alpha-thalassemia. In this review, we examine the causes of alpha-thalassemia in the black population and the consequences of the in
Publikováno v:
Blood. 65:769-771
We have identified a black individual with homozygous sickle cell anemia who is the silent carrier of alpha-thalassemia (genotype - alpha/alpha alpha) due to heterozygosity for the leftward deletion alpha-thal-2 haplotype. This deletion has not been
Autor:
MH Steinberg, SH Embury
Publikováno v:
Blood. 68(5)
Recent advances in molecular genetics have permitted detailed study of the human alpha-globin genes and the causes of alpha-thalassemia. In this review, we examine the causes of alpha-thalassemia in the black population and the consequences of the in
Autor:
SH Boyer, GJ Dover, GR Serjeant, KD Smith, SE Antonarakis, SH Embury, L Margolet, AN Noyes, ML Boyer, WB Bias
Publikováno v:
Blood. 64(5)
Levels of fetal hemoglobin (HbF) bearing reticulocytes (F reticulocytes) range from 2% to 50% in patients with sickle cell (SS) anemia. To learn whether any portion of such variation in F cell production is regulated by loci genetically separable fro
Publikováno v:
Blood. 72(6)
To determine whether the vasoocclusive severity of homozygous sickle cell (SS) disease is influenced by cellular dehydration, we correlated the incidence of painful crisis with steady-state measurements of red cell hydration. Sixteen children with SS
Publikováno v:
International Journal of Gynecology & Obstetrics. 26:168-169
Autor:
Conran N; Hematology Center, University of Campinas-UNICAMP, Barão Geraldo 13083-8, Campinas, SP, Brazil., Embury SH; Vanguard Therapeutics, Inc., California, CA 94019, USA.
Publikováno v:
Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] 2021 Jun; Vol. 246 (12), pp. 1458-1472. Date of Electronic Publication: 2021 Apr 01.
Autor:
Field JJ; Medical Sciences Institute, Versiti Wisconsin, Milwaukee, WI.; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Kassim A; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN., Brandow A; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., Embury SH; Vanguard Therapeutics, Inc., Half Moon Bay, CA; and., Matsui N; Vanguard Therapeutics, Inc., Half Moon Bay, CA; and., Wilkerson K; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN., Bryant V; Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN., Zhang L; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., Simpson P; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., DeBaun MR; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN.; Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN.
Publikováno v:
Blood advances [Blood Adv] 2020 Mar 24; Vol. 4 (6), pp. 1159-1165.
Autor:
Kutlar A; Sickle Cell Center, Department of Medicine, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USA., Embury SH; Department of Medicine, University of California San Francisco School of Medicine, 505 Parnassus Avenue, San Francisco, CA 94143, USA; Vanguard Therapeutics, Inc, 108 Eagle Trace Drive, Half Moon Bay, CA 94019-2286, USA. Electronic address: shembury@gmail.com.
Publikováno v:
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2014 Apr; Vol. 28 (2), pp. 323-39. Date of Electronic Publication: 2014 Jan 17.